Abstract:Small animal fluorescence molecular imaging (FMI) can be a powerful tool for preclinical drug discovery and development studies. However, light absorption by tissue chromophores (e.g., hemoglobin, water, lipids, melanin) typically limits optical signal propagation through thicknesses larger than a few millimeters. Compared to other visible wavelengths, tissue absorption for red and near-infrared (near-IR) light absorption dramatically decreases and non-elastic scattering becomes the dominant light-tissue interaction mechanism. The relatively recent development of fluorescent agents that absorb and emit light in the near-IR range (600-1000 nm), has driven the development of imaging systems and light propagation models that can achieve whole body three-dimensional imaging in small animals. Despite great strides in this area, the ill-posed nature of diffuse fluorescence tomography remains a significant problem for the stability, contrast recovery and spatial resolution of image reconstruction techniques and the optimal approach to FMI in small animals has yet to be agreed on. The majority of research groups have invested in charge-coupled device (CCD)-based systems that provide abundant tissue-sampling but suboptimal sensitivity, while our group and a few others have pursued systems based on very high sensitivity detectors, that at this time allow dense tissue sampling to be achieved only at the cost of low imaging throughput. Here we demonstrate the methodology for applying single-photon detection technology in a fluorescence tomography system to localize a cancerous brain lesion in a mouse model. The fluorescence tomography (FT) system employed single photon counting using photomultiplier tubes (PMT) and information-rich time-domain light detection in a non-contact conformation. This provides a simultaneous collection of transmitted excitation and emission light, and includes automatic fluorescence excitation exposure control, laser referencing, and co-registration with a small animal computed tomography (microCT) system. A nude mouse model was used for imaging. The animal was inoculated orthotopically with a human glioma cell line (U251) in the left cerebral hemisphere and imaged 2 weeks later. The tumor was made to fluoresce by injecting a fluorescent tracer, IRDye 800CW-EGF (LI-COR Biosciences, Lincoln, NE) targeted to epidermal growth factor receptor, a cell membrane protein known to be overexpressed in the U251 tumor line and many other cancers. A second, untargeted fluorescent tracer, Alexa Fluor 647 (Life Technologies, Grand Island, NY) was also injected to account for non-receptor mediated effects on the uptake of the targeted tracers to provide a means of quantifying tracer binding and receptor availability/density. A CT-guided, time-domain algorithm was used to reconstruct the location of both fluorescent tracers (i.e., the location of the tumor) in the mouse brain and their ability to localize the tumor was verified by contrast-enhanced magnetic resonance imaging. Though demonstrated for fluorescence imaging in a glioma mouse model, the methodology presented in this video can be extended to different tumor models in various small animal models potentially up to the size of a rat.

Cryo-Fluorescence Tomography as a Tool for Visualizing Whole-Body Inflammation Using Perfluorocarbon Nanoemulsion Tracers

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Cryo-Imaging and Software Platform for Analysis of Molecular MR Imaging of Micrometastases

A Semi-Automatic Validation Tool for Whole Mouse Metastatic Tumor Molecular Imaging Using the Cryo-Imaging Cancer Imaging and Therapy Platform (CITP)

Computed tomography-guided time-domain diffuse fluorescence tomography in small animals for localization of cancer biomarkers

CT- and MRI-Aided Fluorescence Tomography Reconstructions for Biodistribution Analysis

Imaging Immune Cells Using Fc Domain Probes in Mouse Cancer Xenograft Models

Shortwave Infrared Fluorofluorophores for Multicolor in Vivo Imaging.

Full-Angle Fluorescence Diffuse Optical Tomography with Spatially Coded Parallel Excitation

Customizable, multi-functional fluorocarbon nanoparticles for quantitative in vivo imaging using 19F MRI and optical imaging

Concurrent fluorescence and volumetric optoacoustic tomography of nanoagent perfusion and bio-distribution in solid tumors

Comparing fluorescent contrast agents for fluorescence guided surgery using 3-D cryo-imaging

A combined fluorescence and microcomputed tomography system for small animal imaging.

A pan-cancer agent for screening, resection and wound monitoring via NIR and SWIR imaging

In Vivo High-resolution Ratiometric Fluorescence Imaging of Inflammation Using NIR-II Nanoprobes with 1550 Nm Emission

A Parallel Excitation Based Fluorescence Molecular Tomography System for Whole-Body Simultaneous Imaging of Small Animals

A Fast and Automated FMT/XCT Reconstruction Strategy Based on Standardized Imaging Space

Fluorine-19 MRI for detection and quantification of immune cell therapy for cancer

Fluorescence Imaging of Inflammation with Optical Probes

Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI

Laboratory based correlative cryo-soft X-ray tomography and cryo-fluorescence microscopy